Archives

by in
Entry Author Date Location
We Ask the Xconomists: Some Quick Predictions for the New Year 12/26/13 National
ApoCell Entering the Commercial Ring In Rare Tumor Cell Diagnostics 12/24/13 San Francisco
Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug 12/23/13 Boston
10 Tips for Maximizing the JP Morgan Healthcare Experience 12/23/13 National
Ariad’s Cancer Drug to Return to U.S. in January, Shares Soar 12/20/13 Boston
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
Arrowhead Picks Up Where Roche Left Off, Jumps Ahead in RNAi 12/20/13 Wisconsin
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up 12/19/13 Seattle
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More 12/19/13 San Diego
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
Fresh from IPO, Five Prime Advances Arthritis and Cancer Drugs 12/19/13 San Francisco
Acucela Seeks $125M IPO in Japan to Develop Eye Drugs 12/17/13 Seattle
For CytRx’s Insiders, What a Difference a Day Makes 12/17/13 National
Atara Bio Grabs $38.5M to Help Kidney Patients, Fight Cancer 12/17/13 San Francisco
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
A Revolution is Taking Place in the Treatment of Blood Cancers 12/16/13 National
San Diego Life Sciences Roundup: Orexigen, Accelrys, Otonomy, & More 12/13/13 San Diego
Novartis, Gilead, Genentech & More: An ASH 2013 Wrap-Up 12/10/13 National
Q&A: Behind Ignyta’s New Strategy on Cancer Drugs and Diagnostics 12/09/13 San Diego
12 Things the Pharma Industry Can Do to Rebuild Real Public Trust 12/09/13 National
Connect Honors Roth, Highlights Product Innovation in San Diego 12/06/13 San Diego
Gilead Wins FDA Approval for Big Hepatitis C Drug 12/06/13 San Francisco
San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More 12/06/13 San Diego
San Diego’s Telephus Seeks $5M to Advance Anti-Infective Antibody 12/04/13 San Diego
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Burrill VC Fund Splits into New Firm, Biomark, After Short Marriage 12/03/13 San Francisco
Modern Day Scrooges Are Ruining Our Health Care System 12/03/13 Seattle
PharmAthene Backs Out of Theraclone Sciences Merger 12/02/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
Page 4 of 76 « previous page · next page »